Nanoparticles and Brain Tumor Treatment
Download citation file:
- Ris (Zotero)
- Reference Manager
Gliomas are the most common primary brain tumors in adults, with a worldwide incidence of approximately 7 out of 100,000 individuals per year. Although brain tumors constitute only a small proportion of overall human malignancies, they carry high rates of morbidity and mortality. Mortality is still close to 100% and the average survival of patients with glioblastoma multiforme (GBM) is less than 1 year when classical treatment is used. Recent progress in multimodal treatment of this disease has led to only a slight increase in average survival up to 15–18 months. The effectiveness of the actual chemotherapeutic approach and multimodal targeted therapies remains modest in gliomas.